Skip to content
TrackPodcasts
societySep 15, 202146:42pending

45. Psycholytic therapy with MDMA and LSD with Dr Peter Gasser

About this episode

Today’s episode features Dr Peter Gasser, the president of the Swiss Medical Society for Psycholytic Therapy.

 

Professor Nutt and Dr Gasser talk about the rather unusual and innovative attitude to psychedelic research in Switzerland. 

 

How can Britain learn from the Swiss? What are the drug policies in the Albert Hofmann’s - the discoverer of LSD - country?

 

Dr Peter Gasser is a Swiss psychiatrist and psychotherapist and the President of the Swiss Medical Society for Psycholytic Therapy since 1997. After LSD was criminalized worldwide he was the first person to conduct research on psychedelic-assisted psychotherapy. Additionally, he holds a permission for and provides treatment using MDMA and LSD.

 

MDMA

LSD

Swiss Medical Society for Psycholytic Therapy

International Symposium on the Occasion of the 100th Birthday of Albert Hofmann

Albert Hofmann

Psilocybin

Post-traumatic stress disorder

MAPS - Multidisciplinary Association for Psychedelic Studies

War on drugs - US political campaign 

The Psychedelic Renaissance

Pilot study on LSD-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

End of life anxiety 

Obsessive-compulsive disorder

Cluster headache

Psycholytic therapy with MDMA and LSD in Switzerland - MAPS article 

★ Support this podcast ★

Get every episode summarized

Each time The Drug Science Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.

Email me new episodes

Free for 3 shows. No card needed.

Hosts & guests

No transcript yet

This episode has not been transcribed. Request it and it moves to the front of the queue.

45. Psycholytic therapy with MDMA and LSD with Dr Peter Gasser

The Drug Science Podcast

0:00
46:42

More episodes

More from The Drug Science Podcast

View all episodes →